UAE

Unlike CAR-T therapy, which requires patient-specific cell modification and lengthy manufacturing, this treatment is delivered as a ready-to-use infusion, making it more accessible in standard hospital settings.

Closing this gap would benefit not only patients but also their families and healthcare systems while supporting the Gulf’s broader vision of compassionate, patient-centred care.

The transaction drew robust interest from both regional and international investors, with the orderbook reaching approximately US$1.6 billion, making the offering about 3.2 times oversubscribed.

Developed through a partnership between Masdar City, M42, and Attentive Science, Biosphere Labs aims to address one of the biggest challenges facing researchers and biotechnology companies: access to high-quality laboratory infrastructure.

Unlike conventional EHR systems that add AI as an extra feature, IntelliCare places artificial intelligence at the centre of the clinical workflow.

The three-day programme, developed in collaboration with JointGlow, will bring together radiation oncologists, medical physicists, radiation therapists, informatics specialists, healthcare administrators, and other clinical leaders.

The ISO standard evaluates the entire diagnostic process, from sample collection to reporting, ensuring laboratories consistently produce reliable results.

The transaction concludes a phased investment strategy that steadily increased Amanat’s control over the group.

Jascayd® acts as a selective inhibitor of phosphodiesterase-4B (PDE4B), a biological pathway linked to inflammation and fibrotic processes in the lungs.

The award places the Centre among the leading innovators in healthcare, particularly in neurotechnology and personalised rehabilitation.